Cargando…

1702. Disseminated Candidiasis after Candidemia: Epidemiology, Diagnostic Evaluation, and Risk Factors

BACKGROUND: In patients with candidemia, evaluation for disseminated disease with ophthalmological exam and diagnostic imaging is recommended but not standardized. This study sought to describe practice patterns in the diagnostic evaluation for disseminated disease after candidemia and identify risk...

Descripción completa

Detalles Bibliográficos
Autores principales: Whitehurst, Daniel, Murphy, Catherine R, Teoh, Zheyi, Brammer, Caitlin N, Perkins, Kerrigan, Paulsen, Grant C, Danziger-Isakov, Lara A, Miller-Handley, Hilary, Otto, William R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678369/
http://dx.doi.org/10.1093/ofid/ofad500.1535
_version_ 1785150345101443072
author Whitehurst, Daniel
Murphy, Catherine R
Teoh, Zheyi
Brammer, Caitlin N
Perkins, Kerrigan
Paulsen, Grant C
Danziger-Isakov, Lara A
Miller-Handley, Hilary
Otto, William R
author_facet Whitehurst, Daniel
Murphy, Catherine R
Teoh, Zheyi
Brammer, Caitlin N
Perkins, Kerrigan
Paulsen, Grant C
Danziger-Isakov, Lara A
Miller-Handley, Hilary
Otto, William R
author_sort Whitehurst, Daniel
collection PubMed
description BACKGROUND: In patients with candidemia, evaluation for disseminated disease with ophthalmological exam and diagnostic imaging is recommended but not standardized. This study sought to describe practice patterns in the diagnostic evaluation for disseminated disease after candidemia and identify risk factors associated with disseminated candidiasis to improve local management. METHODS: A retrospective study of all episodes of candidemia diagnosed in patients < 25 years from 2013-2022 at Cincinnati Children’s Hospital Medical Center reported clinical characteristics, microbiology data, and diagnostic testing for dissemination. Disseminated candidiasis was defined as an ophthalmologic exam, echocardiogram or other imaging findings consistent with candidiasis or growth of Candida spp. from a sterile site besides blood. Mixed-effects logistic regression was performed to identify risk factors for disseminated disease. RESULTS: 144 episodes of candidemia occurred in 124 patients , with C. albicans (35%) the most commonly identified species (Figure 1). 107/144 (74.3%) episodes underwent evaluation for disseminated candidiasis, with dissemination in 27/107 (25.2%). Of patients with only 1 positive culture, 5/34 (14.7%) had disseminated candidiasis compared to 22/73 (30.1%) with more than 1 positive culture (Figure 2). Ophthalmologic exams and echocardiograms were done in < 70% of workups (Figure 3). History of prematurity (aOR 17.5, 95%CI 3.1-100.4) and solid organ transplantation (aOR 5.3, 95%CI 1.1-24.6) were associated with disseminated candidiasis when controlling for age, sex, underlying disease, and initial antifungal treatment. Each additional day of candidemia significantly increased the odds of dissemination (aOR 1.5, 95%CI 1.2-1.9). [Figure: see text] [Figure: see text] [Figure: see text] CONCLUSION: In this single-center study, most patients with candidemia underwent diagnostic evaluation, though the extent varied. Disseminated disease was common. Prematurity and history of solid organ transplantation were independent risk factors for dissemination as was each additional day of candidemia. Patients with any candidemia should undergo evaluation for dissemination. Multicenter studies are needed to determine the optimal diagnostic evaluation in these high-risk patient groups. DISCLOSURES: Grant C. Paulsen, MD, Moderna: Grant/Research Support|Pfizer: Grant/Research Support Lara A. Danziger-Isakov, MD, MPH, Aicuris: Contracted Clinical Research|Ansun Biopharma: Contracted Clinical Research|Astellas: Contracted Clinical Research|GSK: Advisor/Consultant|Merck: Advisor/Consultant|Merck: Contracted Clinical Research|Pfizer: Contracted Clinical Research|Roche Diagnostics: Advisor/Consultant|Takeda: Advisor/Consultant|Takeda: Contracted Clinical Research William R. Otto, MD, MSCE, Moderna: Grant/Research Support
format Online
Article
Text
id pubmed-10678369
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-106783692023-11-27 1702. Disseminated Candidiasis after Candidemia: Epidemiology, Diagnostic Evaluation, and Risk Factors Whitehurst, Daniel Murphy, Catherine R Teoh, Zheyi Brammer, Caitlin N Perkins, Kerrigan Paulsen, Grant C Danziger-Isakov, Lara A Miller-Handley, Hilary Otto, William R Open Forum Infect Dis Abstract BACKGROUND: In patients with candidemia, evaluation for disseminated disease with ophthalmological exam and diagnostic imaging is recommended but not standardized. This study sought to describe practice patterns in the diagnostic evaluation for disseminated disease after candidemia and identify risk factors associated with disseminated candidiasis to improve local management. METHODS: A retrospective study of all episodes of candidemia diagnosed in patients < 25 years from 2013-2022 at Cincinnati Children’s Hospital Medical Center reported clinical characteristics, microbiology data, and diagnostic testing for dissemination. Disseminated candidiasis was defined as an ophthalmologic exam, echocardiogram or other imaging findings consistent with candidiasis or growth of Candida spp. from a sterile site besides blood. Mixed-effects logistic regression was performed to identify risk factors for disseminated disease. RESULTS: 144 episodes of candidemia occurred in 124 patients , with C. albicans (35%) the most commonly identified species (Figure 1). 107/144 (74.3%) episodes underwent evaluation for disseminated candidiasis, with dissemination in 27/107 (25.2%). Of patients with only 1 positive culture, 5/34 (14.7%) had disseminated candidiasis compared to 22/73 (30.1%) with more than 1 positive culture (Figure 2). Ophthalmologic exams and echocardiograms were done in < 70% of workups (Figure 3). History of prematurity (aOR 17.5, 95%CI 3.1-100.4) and solid organ transplantation (aOR 5.3, 95%CI 1.1-24.6) were associated with disseminated candidiasis when controlling for age, sex, underlying disease, and initial antifungal treatment. Each additional day of candidemia significantly increased the odds of dissemination (aOR 1.5, 95%CI 1.2-1.9). [Figure: see text] [Figure: see text] [Figure: see text] CONCLUSION: In this single-center study, most patients with candidemia underwent diagnostic evaluation, though the extent varied. Disseminated disease was common. Prematurity and history of solid organ transplantation were independent risk factors for dissemination as was each additional day of candidemia. Patients with any candidemia should undergo evaluation for dissemination. Multicenter studies are needed to determine the optimal diagnostic evaluation in these high-risk patient groups. DISCLOSURES: Grant C. Paulsen, MD, Moderna: Grant/Research Support|Pfizer: Grant/Research Support Lara A. Danziger-Isakov, MD, MPH, Aicuris: Contracted Clinical Research|Ansun Biopharma: Contracted Clinical Research|Astellas: Contracted Clinical Research|GSK: Advisor/Consultant|Merck: Advisor/Consultant|Merck: Contracted Clinical Research|Pfizer: Contracted Clinical Research|Roche Diagnostics: Advisor/Consultant|Takeda: Advisor/Consultant|Takeda: Contracted Clinical Research William R. Otto, MD, MSCE, Moderna: Grant/Research Support Oxford University Press 2023-11-27 /pmc/articles/PMC10678369/ http://dx.doi.org/10.1093/ofid/ofad500.1535 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstract
Whitehurst, Daniel
Murphy, Catherine R
Teoh, Zheyi
Brammer, Caitlin N
Perkins, Kerrigan
Paulsen, Grant C
Danziger-Isakov, Lara A
Miller-Handley, Hilary
Otto, William R
1702. Disseminated Candidiasis after Candidemia: Epidemiology, Diagnostic Evaluation, and Risk Factors
title 1702. Disseminated Candidiasis after Candidemia: Epidemiology, Diagnostic Evaluation, and Risk Factors
title_full 1702. Disseminated Candidiasis after Candidemia: Epidemiology, Diagnostic Evaluation, and Risk Factors
title_fullStr 1702. Disseminated Candidiasis after Candidemia: Epidemiology, Diagnostic Evaluation, and Risk Factors
title_full_unstemmed 1702. Disseminated Candidiasis after Candidemia: Epidemiology, Diagnostic Evaluation, and Risk Factors
title_short 1702. Disseminated Candidiasis after Candidemia: Epidemiology, Diagnostic Evaluation, and Risk Factors
title_sort 1702. disseminated candidiasis after candidemia: epidemiology, diagnostic evaluation, and risk factors
topic Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678369/
http://dx.doi.org/10.1093/ofid/ofad500.1535
work_keys_str_mv AT whitehurstdaniel 1702disseminatedcandidiasisaftercandidemiaepidemiologydiagnosticevaluationandriskfactors
AT murphycatheriner 1702disseminatedcandidiasisaftercandidemiaepidemiologydiagnosticevaluationandriskfactors
AT teohzheyi 1702disseminatedcandidiasisaftercandidemiaepidemiologydiagnosticevaluationandriskfactors
AT brammercaitlinn 1702disseminatedcandidiasisaftercandidemiaepidemiologydiagnosticevaluationandriskfactors
AT perkinskerrigan 1702disseminatedcandidiasisaftercandidemiaepidemiologydiagnosticevaluationandriskfactors
AT paulsengrantc 1702disseminatedcandidiasisaftercandidemiaepidemiologydiagnosticevaluationandriskfactors
AT danzigerisakovlaraa 1702disseminatedcandidiasisaftercandidemiaepidemiologydiagnosticevaluationandriskfactors
AT millerhandleyhilary 1702disseminatedcandidiasisaftercandidemiaepidemiologydiagnosticevaluationandriskfactors
AT ottowilliamr 1702disseminatedcandidiasisaftercandidemiaepidemiologydiagnosticevaluationandriskfactors